SLGL Sol-Gel Technologies Ltd

  1. Stocks
  2. Healthcare
  3. NASDAQ: SLGL

Price (delayed)

$81.96

Market cap

$267.93M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.33

Enterprise value

$258.65M

?
Relative Growth: Rel. Growth: 76
Relative Strength: Rel. Strength: 98
Relative Valuation: Rel. Valuation: 7
Relative Profitability: Rel. Profitability: 54

Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead ...

Highlights
SLGL's equity has surged by 125% since the previous quarter
SLGL's quick ratio has soared by 103% since the previous quarter
The company's gross profit has surged by 66% YoY but it fell by 5% QoQ
SLGL's revenue has soared by 66% year-on-year but it is down by 5% since the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://www.sol-gel.com

Key stats

What are the main financial stats of SLGL

SLGL stock price

How has the Sol-Gel Technologies stock price performed over time
Intraday
1.75%
1 week
-1.49%
1 month
11.66%
1 year
637.71%
YTD
94.49%
QTD
10.55%

Financial performance

How have Sol-Gel Technologies's revenue and profit performed over time
Revenue
$18.36M
Gross profit
$18.36M
Operating income
-$2.49M
Net income
-$1.05M
Gross margin
100%
Net margin
-5.7%
The company's net margin has surged by 95% YoY and by 82% QoQ
The net income has soared by 92% YoY and by 83% from the previous quarter
The company's operating margin has surged by 90% YoY and by 66% QoQ
The operating income has surged by 84% year-on-year and by 67% since the previous quarter

Price vs fundamentals

How does SLGL's price correlate with its fundamentals

Growth

What is Sol-Gel Technologies's growth rate over time

Valuation

What is Sol-Gel Technologies stock price valuation
P/E
N/A
P/B
4.44
P/S
12.67
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
14.09
The EPS has soared by 93% YoY and by 85% from the previous quarter
SLGL's equity has surged by 125% since the previous quarter
SLGL's price to book (P/B) is 93% more than its 5-year quarterly average of 2.3 and 35% more than its last 4 quarters average of 3.3
SLGL's price to sales (P/S) is 115% more than its last 4 quarters average of 5.9 but 7% less than its 5-year quarterly average of 13.6
SLGL's revenue has soared by 66% year-on-year but it is down by 5% since the previous quarter

Efficiency

How efficient is Sol-Gel Technologies business performance
The ROS has soared by 95% YoY and by 82% from the previous quarter
Sol-Gel Technologies's return on invested capital has surged by 91% QoQ
The return on assets has surged by 86% since the previous quarter
Sol-Gel Technologies's ROE has soared by 86% from the previous quarter

Dividends

What is SLGL's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SLGL.

Financial health

How did Sol-Gel Technologies financials performed over time
SLGL's quick ratio has soared by 103% since the previous quarter
SLGL's current ratio has surged by 102% since the previous quarter
The company's debt is 98% lower than its equity
SLGL's equity has surged by 125% since the previous quarter
SLGL's debt to equity has dropped by 50% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.